---
title: "Paxlovid (nirmatrelvir; ritonavir), all indications: Access and coverage questions"
description: "Access and coverage questions on Paxlovid (nirmatrelvir; ritonavir) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing and Patient support. Questions: What are the NDC numbers for Paxlovid? Who can HCPs contact with medical questions about Paxlovid? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/paxlovid/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Paxlovid (nirmatrelvir; ritonavir), all indications: Access and coverage questions

Manufacturer: Pfizer Inc  
Prescribing information: [Paxlovid](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599)  
Indication pages: [COVID-19](https://www.evicenter.com/medical-information/paxlovid--covid-19)

## Access and billing

<a id="paxlovid-ndc"></a>

### What are the NDC numbers for Paxlovid?

> “Dose Pack
>
>
>
> Content
>
>
>
> NDC
>
>
>
> Description
>
>
>
>
> 300 mg nirmatrelvir;
> 100 mg ritonavir
>
>
>
> Each Carton Contains:
>
> 30 tablets divided in
> 10 blister cards
>
>
>
> 0069-5045-30
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White to off-white, capsule-shaped, film-coated tablets debossed with "H" on one side and “R9” on the other side.
>
>
>
>
>
> Or
>
>
>
>
>
>
> 0069-5321-30
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White film-coated ovaloid tablets debossed with "NK" on one side.
>
>
>
>
> Each Blister Card Contains:
>
> 2 nirmatrelvir tablets
> (150 mg each) and
> 1 ritonavir tablet
> (100 mg)
>
>
>
> 0069-5045-06
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White to off-white, capsule-shaped, film-coated tablets debossed with "H" on one side and “R9” on the other side.
>
>
>
>
>
> Or
>
>
>
>
>
>
> 0069-5321-03
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White film-coated ovaloid tablets debossed with "NK" on one side.
>
>
>
>
> 150 mg nirmatrelvir;
> 100 mg ritonavir
>
>
>
> Each Carton Contains:
>
> 20 tablets divided in
> 10 blister cards
>
>
>
> 0069-5317-20
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White film-coated ovaloid tablets debossed with “NK” on one side.
>
>
>
>
>
> Or
>
>
>
>
>
>
> 0069-5434-20
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White to off-white, capsule-shaped, film-coated tablets debossed with “H” on one side and “R9” on the other side.
>
>
>
>
> Each Blister Card Contains:
>
>
> 1 nirmatrelvir tablet
> (150 mg) and
> 1 ritonavir tablet
> (100 mg)
>
>
>
> 0069-5317-02
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White film-coated ovaloid tablets debossed with “NK” on one side.
>
>
>
>
>
> Or
>
>
>
>
>
>
> 0069-5434-02
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White to off-white, capsule-shaped, film-coated tablets debossed with “H” on one side and “R9” on the other side.
>
>
>
>
> 300 mg nirmatrelvir;
> 100 mg ritonavir (Day 1)
>
> 150 mg nirmatrelvir;
> 100 mg ritonavir (Days 2-5)
>
>
>
> Each Carton Contains:
>
> 11 tablets in
> 1 blister card
>
>
>
> 0069-0521-11
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White film-coated ovaloid tablets debossed with “NK” on one side.
>
>
>
>
>
> Or
>
>
>
>
>
>
> 0069-5450-11
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White to off-white, capsule-shaped, film-coated tablets debossed with “H” on one side and “R9” on the other side.
>
>
>
>
> Each Blister Card Contains:
>
> 6 nirmatrelvir tablets
> (150 mg) and
> 5 ritonavir tablets
> (100 mg)
>
>
>
> 0069-0521-11
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White film-coated ovaloid tablets debossed with “NK” on one side.
>
>
>
>
>
> Or
>
>
>
>
>
>
> 0069-5450-11
>
>
>
> Nirmatrelvir tablets: Oval, pink immediate-release, film-coated tablets debossed with "PFE" on one side and "3CL" on the other side.
>
> Ritonavir tablets: White to off-white, capsule-shaped, film-coated tablets debossed with “H” on one side and “R9” on the other side.”

Source: [PAXLOVID: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=19599#:~:text=Dose%20Pack,%E2%80%9CH%E2%80%9D%20on%20one%20side%20and%20%E2%80%9CR9%E2%80%9D%20on%20the%20other%20side.)

Note: Each NDC row is followed by the tablet description for that package; "Or" separates the two package versions of each dose pack.

## Patient support

<a id="paxlovid-medical-information"></a>

### Who can HCPs contact with medical questions about Paxlovid?

> “For medical questions related to PAXLOVID, you can visit pfizermedicalinformation.com or call Medical Information at 1-800-438-1985.”

Source: [PAXLOVID: FAQs, captured 2026-11-13](https://paxlovid.pfizerpro.com/access-resources/faqs#:~:text=For%20medical%20questions%20related%20to,call%20Medical%20Information%20at%201%2D800%2D438%2D1985.)

## Related pages
- [Medical information: Paxlovid (nirmatrelvir; ritonavir): All indications](https://www.evicenter.com/medical-information/paxlovid)
- [Indication](https://www.evicenter.com/medical-information/paxlovid/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/paxlovid/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/paxlovid/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/paxlovid/safety)
- [Specific populations](https://www.evicenter.com/medical-information/paxlovid/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/paxlovid/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/paxlovid/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/paxlovid/storage-and-supply)
